Catherine R. Copeland

Author

Also Known As

C. Copeland, C. R. COPELAND, Catherine R. Copeland, Copeland, C.R.

Publications

149

Citations

H-Index

Concepts

All Affiliations

Catherine R. Copeland is an author at Public Health Agency of Canada specializing in organic chemistry, chemistry, and medicinal chemistry.

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	3	3	104
2	Engineering	2	2	56
3	Medicine	2	2	70
4	Biochemistry	2	2	49
5	Biomolecular Engineering	1	1	22

Catherine R. Copeland

Publications

145

Citations

H-Index

Page 1

	Year	Citations
Chemical analysis of two new designer drugs: buphedrone and pentedrone Chad R. Maheux, Catherine R. Copeland Drug Testing and Analysis Pharmaceutical ScienceHydrochloride SaltsOrganic ChemistryPharmacotherapyChemistry	2011	55
Characterization of Three Methcathinone Analogs: 4-Methylmethcathinone, Methylone, and bk-MBDB Chad R. Maheux, Catherine R. Copeland, Michael M. Pollard Complete Spectroscopic CharacterizationCombinatorial ChemistryMedicinal ChemistryDerivative (Chemistry)Engineering	2010	34
Selective side-chain bromination of n-acyl-2,3-dialkylindoles: synthesis and chemical modification of pyrrolo[1,2-a]indoles Susan F. Vice, Catherine R. Copeland, Steven P. Forsey, Tetrahedron Letters EngineeringSelective Side-chain BrominationChemical ModificationOrganic ChemistryStereoselective Synthesis	1985	22
Identification of polymorphism in ethylone hydrochloride: synthesis and characterization Chad R. Maheux, Idralyn Q. Alarcon, Catherine R. Copeland, Drug Testing and Analysis	2015	19
Inhibition of β-lactamase-I by 6-β-sulfonamidopenicillanic acid sulfones: Evidence for conformational change accompanying the inhibition process Gary I. Dmitrienko, Catherine R. Copeland, Lee D. Arnold, Bioorganic Chemistry 6-β-Sulfonamidopenicillanic Acid SulfonesAntimicrobial ChemotherapyChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	1985	15

Page 1